Back to Swiss National Bank Swiss National Bank

TEVATEVA
Showing 8 of 31 quarters

Position history for Swiss National BankSwiss National Bank's holdings in TEVA PHARMACEUTICAL-SP ADR

Swiss National Bank holds 4.1M shares of TEVA (TEVA PHARMACEUTICAL-SP ADR), worth $139.6M as of 2026-Q2. The position was decreased (-2.5% shares). TEVA represents 0.1% of Swiss National Bank's portfolio.

Current Value

$139.6M

Current Shares

4.1M

Total Value Change

+$79.4M

Total Shares Change

+778,800

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.1M
-2.5%
$139.6M0.1%$33.88
0
2026-Q1
Increased
4.2M
+28.7%
$127.3M0.1%$32.28
38
2025-Q4
Decreased
3.3M
-4.2%
$102.6M0.1%$31.34
0
2025-Q3
Decreased
3.4M
-5.2%
$69.3M0.0%$19.18
0
2025-Q2
Increased
3.6M
+15.5%
$60.6M0.0%$16.76
34
2025-Q1
Increased
3.1M
+0.1%
$48.1M0.0%$15.08
29
2024-Q4
Decreased
3.1M
-6.4%
$68.9M0.0%$22.32
0
2024-Q3
Increased
3.3M
+0.5%
$60.2M0.0%$17.46
29

Other major holders of TEVA: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used